Ozempic may reduce alcohol consumption, new research suggests

New research suggests that semaglutide — the active ingredient in GLP-1 drugs such as Ozempic — may have potential as a treatment for alcohol misuse. Originally developed for diabetes, these drugs are already used by millions of Americans for weight loss. Scientists indicate that GLP-1 receptor agonists may act on the brain's reward centres involved in addiction.